Literature DB >> 2438184

Characterization and tissue specificity of a monoclonal antibody against human uridine 5'-diphosphate-glucuronosyltransferase.

W H Peters, W A Allebes, P L Jansen, L G Poels, P J Capel.   

Abstract

A monoclonal antibody against human liver uridine 5'-diphosphate-glucuronosyltransferase (UDPGTase) was developed. Enzyme inhibition studies with this monoclonal antibody showed inhibition of human liver UDPGTase activity with bilirubin, 4-methylumbelliferone, and 4-nitrophenol as substrates. Testosterone, estrone, and phenolphthalein UDPGTase activity was not inhibited. The monoclonal antibody probably recognizes the uridine 5'-diphosphate-glucuronic acid binding site at 4-nitrophenol UDPGTase. Proteins with a molecular mass of 54,000 daltons were immunopurified from solubilized human liver using the monoclonal antibody as ligand coupled to Sepharose 4B beads. The distribution of UDPGTase isoforms in various human tissues was studied by immunofluorescence. The enzyme could be detected in liver, kidney, stomach, small intestine, colon, and skin. In liver, only hepatocytes contain UDPGTase. In kidney, the enzyme was localized exclusively in proximal tubuli and in stomach in epithelial mucous cells. In small intestinal epithelium, maximal fluorescence was seen at the villous tip. In colon, all lining epithelial cells were stained. In colon polyps, staining for UDPGTase was clearly decreased, and in colon carcinoma it was undetectable. In skin, the stratum corneum was intensely stained, whereas the stratum basale showed no fluorescence.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2438184     DOI: 10.1016/0016-5085(87)90329-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  19 in total

1.  Biotransformation enzymes in human intestine: critical low levels in the colon?

Authors:  W H Peters; L Kock; F M Nagengast; P G Kremers
Journal:  Gut       Date:  1991-04       Impact factor: 23.059

2.  Immunochemical analysis of uridine diphosphate-glucuronosyltransferase in four patients with the Crigler-Najjar syndrome type I.

Authors:  H H van Es; B G Goldhoorn; M Paul-Abrahamse; R P Elferink; P L Jansen
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

Review 3.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

4.  MALDI Mass Spectrometry Imaging for Evaluation of Therapeutics in Colorectal Tumor Organoids.

Authors:  Xin Liu; Colin Flinders; Shannon M Mumenthaler; Amanda B Hummon
Journal:  J Am Soc Mass Spectrom       Date:  2017-12-05       Impact factor: 3.109

5.  Genetic deficiency of human class mu glutathione S-transferase isoenzymes in relation to the urinary excretion of the mercapturic acids of Z- and E-1,3-dichloropropene.

Authors:  R M Vos; R T van Welie; W H Peters; C T Evelo; J J Boogaards; N P Vermeulen; P J van Bladeren
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

6.  Importance of UDP-glucuronosyltransferase 1A1 expression in skin and its induction by UVB in neonatal hyperbilirubinemia.

Authors:  Kyohei Sumida; Makiko Kawana; Emi Kouno; Tomoo Itoh; Shuhei Takano; Tomoya Narawa; Robert H Tukey; Ryoichi Fujiwara
Journal:  Mol Pharmacol       Date:  2013-08-15       Impact factor: 4.436

7.  Developmental aspects of human hepatic drug glucuronidation in young children and adults.

Authors:  C P Strassburg; A Strassburg; S Kneip; A Barut; R H Tukey; B Rodeck; M P Manns
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

8.  Oral tolerization to adenoviral antigens permits long-term gene expression using recombinant adenoviral vectors.

Authors:  Y Ilan; R Prakash; A Davidson; G Droguett; M S Horwitz; N R Chowdhury; J R Chowdhury
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

9.  Lifelong elimination of hyperbilirubinemia in the Gunn rat with a single injection of helper-dependent adenoviral vector.

Authors:  Gabriele Toietta; Viraj P Mane; Wilma S Norona; Milton J Finegold; Philip Ng; Antony F McDonagh; Arthur L Beaudet; Brendan Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

10.  Differential localisation of UDP-glucuronosyltransferase in kidney during human embryonic and fetal development.

Authors:  R Hume; M W Coughtrie; B Burchell
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.